The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
基本信息
- 批准号:10569113
- 负责人:
- 金额:$ 33.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-09 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAntigen-Presenting CellsAryl Hydrocarbon ReceptorAsthmaAutoimmune DiseasesAutoimmunityB-LymphocytesBindingBinding SitesBiologicalBone MarrowCell physiologyCellsChronic DiseaseCommunicable DiseasesCommunicationDNA BindingDataDendritic CellsDevelopmentDioxinsElementsEnvironmental PollutantsEnvironmental Risk FactorEventExposure toFutureGene ExpressionGene Expression ProfilingGenesGeneticGenomeGoalsHealthHumanHypersensitivityIL12A geneImmuneImmune System DiseasesImmune responseImmune systemImmunityImmunoglobulin FragmentsImmunologic Deficiency SyndromesImmunologic MonitoringImmunomodulatorsImmunosuppressionInfectionInflammationInflammatoryInflammatory ResponseInterleukin-1 betaInterleukin-6Knockout MiceLeadLigandsLinkLocationLogicLymphocyteMacrophageMapsMediatingMethodsModelingMolecularMonitorMusNF-kappa BOutcomePathologicPathway interactionsPhysiologicalPlayPositron-Emission TomographyProcessProteinsREL ProteinRadioimmunoconjugateReceptor ActivationReceptor SignalingRegulationRegulatory T-LymphocyteReportingRepressor ProteinsRoleSchemeShockSignal PathwaySignal TransductionStimulusSurface AntigensT cell differentiationT-Cell ActivationT-LymphocyteTestingTimeTissuesToll-like receptorsToxic Environmental SubstancesToxic effectTranscription RepressorTransgenic MiceWorkaryl hydrocarbon receptor ligandcell typechromatin immunoprecipitationchronic inflammatory diseasecytokinegenome-wide analysisimmune activationimmune system functionimmunoreactionimmunoregulationimmunotoxicityin vivoinnovationinsightmolecular targeted therapiesmonocytemouse modelmutantneutrophilnoveloverexpressionpathogenprotein protein interactionreceptorrecruitresponsesensor
项目摘要
Project Summary/Abstract
The aryl hydrocarbon receptor (AhR) plays an important role in regulating immune responses and exposure to
AhR-activating compounds, including environmental toxicants such as dioxins may contribute to the
dysregulation of cytokines and the development of immune system disorders. The ligand-dependent activation
of AhR can promote differentiation of inflammatory T helper Th17 cells or lead to profound immunosuppression
and an increase of regulatory T cells. Significant gaps exist in our understanding of how the AhR regulates the
inter- and intracellular communication processes between dendritic cells (DC) and other immune cells on the
molecular level, which is of central importance to understanding both physiologic and pathophysiologic immune
reactions mediated through AhR. The overall goal of this proposal is to identify the functional role of the AhR and
its specific repressor (AhRR) interacting with Toll-like receptor (TLR) and NFkB signaling in controlling function
and differentiation of DC and T-cell activation. The reported dysregulation of TLR and NFkB signaling by AhR
ligands may be key steps in triggering immune system disorders. The transcriptional repressor of the AhR, the
AhRR is implemented in the AhR pathway, although much remains to be elucidated at the level of TLR and
NFkB signaling. In transgenic mice overexpressing AhRR we discovered that AhRR is critically involved in
regulation of dioxin-induced inflammatory gene expression as well as LPS-mediated inflammatory responses
and LPS shock. Thus, the AhRR Tg mice give us the opportunity to recognize how AhRR is involved in the
regulation of TLR-mediated responses and other parts of the immune system. Bone-marrow derived DC from
genetic mouse models as well as human DC, will be used to investigate how DC are regulated through ligand-
induced activation of the AhR and inflammatory signals via TLR/NFkB. A genome-wide identification of AhR/Rel
binding sites will be conducted and related to gene expression analysis. Mutants of binding sites will be
generated to validate whether a particular binding event is actually required to regulate the expression of target
genes. Protein-protein interaction studies will identify the specific interacting domains of AhR and Rel proteins
and provide insight into how these interactions impact the functional activity of each protein and the outcome of
AhR/NFkB crosstalk. A novel in vivo method to monitor immune responses noninvasively via Positron Emission
Tomography (immuno-PET) imaging will be used to ultimately show how AhR ligands modify TLR-mediated
recruitment and accumulation of DC, neutrophils, B cells, and T cells in vivo. This study can provide a definite
link and mechanism between the exposure to AhR activating compounds and the development of inflammatory
chronic diseases. Findings will allow for more clearly defined endpoints to assess the effects and toxicity of AhR
activating ligands including environmental pollutants. This study will also provide new concepts for future
innovative uses of AhR and AhRR as molecular targets for therapeutic applications in inflammation, infection,
and chronic diseases.
项目概要/摘要
芳烃受体 (AhR) 在调节免疫反应和暴露于环境中发挥着重要作用
AhR 激活化合物,包括二恶英等环境毒物,可能会导致
细胞因子失调和免疫系统疾病的发展。配体依赖性激活
AhR 可以促进炎症辅助性 T Th17 细胞的分化或导致严重的免疫抑制
以及调节性 T 细胞的增加。我们对 AhR 如何监管的理解存在重大差距
树突状细胞(DC)和其他免疫细胞之间的细胞间和细胞内通讯过程
分子水平,这对于理解生理和病理生理免疫至关重要
通过 AhR 介导的反应。该提案的总体目标是确定 AhR 的职能角色和
其特异性阻遏蛋白 (AhRR) 与 Toll 样受体 (TLR) 和 NFkB 信号传导相互作用以控制功能
以及 DC 和 T 细胞激活的分化。据报道,AhR 对 TLR 和 NFkB 信号传导失调
配体可能是引发免疫系统疾病的关键步骤。 AhR 的转录抑制因子
AhRR 是在 AhR 途径中实现的,尽管在 TLR 和
NFkB 信号传导。在过度表达 AhRR 的转基因小鼠中,我们发现 AhRR 关键参与
二恶英诱导的炎症基因表达以及脂多糖介导的炎症反应的调节
和LPS休克。因此,AhRR Tg 小鼠让我们有机会了解 AhRR 如何参与
调节 TLR 介导的反应和免疫系统的其他部分。骨髓衍生的 DC
遗传小鼠模型以及人类 DC,将用于研究 DC 如何通过配体进行调节
通过 TLR/NFkB 诱导 AhR 和炎症信号的激活。 AhR/Rel 的全基因组鉴定
将进行结合位点和与基因表达相关的分析。结合位点的突变体将是
生成以验证是否确实需要特定的结合事件来调节目标的表达
基因。蛋白质-蛋白质相互作用研究将确定 AhR 和 Rel 蛋白质的特定相互作用域
并深入了解这些相互作用如何影响每种蛋白质的功能活性以及结果
AhR/NFkB 串扰。一种通过正电子发射无创监测免疫反应的新型体内方法
断层扫描(免疫 PET)成像将用于最终显示 AhR 配体如何修改 TLR 介导的
DC、中性粒细胞、B 细胞和 T 细胞在体内的募集和积累。这项研究可以提供明确的
暴露于 AhR 激活化合物与炎症发展之间的联系和机制
慢性疾病。研究结果将允许更明确定义的终点来评估 AhR 的效果和毒性
激活配体,包括环境污染物。这项研究也将为未来提供新的概念
AhR 和 AhRR 作为分子靶标的创新用途,用于炎症、感染、
和慢性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPH F A VOGEL其他文献
CHRISTOPH F A VOGEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPH F A VOGEL', 18)}}的其他基金
The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
- 批准号:
10367788 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Air pollution, atherosclerosis, and the role of the aryl hydrocarbon receptor
空气污染、动脉粥样硬化和芳烃受体的作用
- 批准号:
10316177 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Air pollution, atherosclerosis, and the role of the aryl hydrocarbon receptor
空气污染、动脉粥样硬化和芳烃受体的作用
- 批准号:
10540334 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
The protective role of the AhR Repressor in breast cancer development
AhR 阻遏物在乳腺癌发展中的保护作用
- 批准号:
9918372 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Importance of AhR for the cellular function and communication of dendritic cells
AhR 对树突状细胞的细胞功能和通讯的重要性
- 批准号:
8239472 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Importance of AhR for the cellular function and communication of dendritic cells
AhR 对树突状细胞的细胞功能和通讯的重要性
- 批准号:
8667446 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Importance of AhR for the cellular function and communication of dendritic cells
AhR 对树突状细胞的细胞功能和通讯的重要性
- 批准号:
8518324 - 财政年份:2012
- 资助金额:
$ 33.87万 - 项目类别:
Role of Aryl hydrocarbon receptor (AhR) and RelB during the initiation of dendrit
芳烃受体 (AhR) 和 RelB 在树突形成过程中的作用
- 批准号:
7895003 - 财政年份:2009
- 资助金额:
$ 33.87万 - 项目类别:
Role of Aryl hydrocarbon receptor (AhR) and RelB during the initiation of dendrit
芳烃受体 (AhR) 和 RelB 在树突形成过程中的作用
- 批准号:
7740312 - 财政年份:2009
- 资助金额:
$ 33.87万 - 项目类别:
相似国自然基金
基于DNA自组装技术的人工抗原呈递细胞设计构建及其免疫功能评价
- 批准号:21907073
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
具有温度/pH双重响应和甘露糖受体靶向功能的微凝胶疫苗
- 批准号:51903233
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
高同型半胱氨酸血症放大高脂引起动脉粥样硬化早期发病--管周脂肪的抗原呈递作用
- 批准号:91439206
- 批准年份:2014
- 资助金额:270.0 万元
- 项目类别:重大研究计划
内淋巴囊上皮细胞在内耳免疫调控作用中的分子机制研究
- 批准号:81371084
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
- 批准号:30771999
- 批准年份:2007
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
The impact of Aryl hydrocarbon receptor signaling on Toll like receptor-mediated inflammation
芳基碳氢化合物受体信号传导对 Toll 样受体介导的炎症的影响
- 批准号:
10367788 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Role of probiotic Lactobacillus reuteri in orchestrating systemic anti-tumor immunity
益生菌罗伊氏乳杆菌在协调全身抗肿瘤免疫中的作用
- 批准号:
10586109 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Role of probiotic Lactobacillus reuteri in orchestrating systemic anti-tumor immunity
益生菌罗伊氏乳杆菌在协调全身抗肿瘤免疫中的作用
- 批准号:
10417677 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Detrimental effects of age-related gut dysbiosis on stroke outcomes are mediated via the aryl hydrocarbon receptor
与年龄相关的肠道菌群失调对中风结果的有害影响是通过芳基烃受体介导的
- 批准号:
10217060 - 财政年份:2020
- 资助金额:
$ 33.87万 - 项目类别:
Novel ARNT-mediated Regulatory Paradigm of AhR signaling
新型 ARNT 介导的 AhR 信号调节范式
- 批准号:
9107149 - 财政年份:2016
- 资助金额:
$ 33.87万 - 项目类别: